Figure 10.

Expression of common immune checkpoint inhibitor genes and targeted genes under MTG-based prognostic signature stratification and their effect on clinical prognosis of patients with ccRCC. The expression levels of immune checkpoint genes and targeted genes were compared between high-risk and low-risk groups in TCGA cohort. (a) KDR; (b) KIT; (c) VEGFA; (d) PD-1; (e) PD-L1; (f) CTLA4. Kaplan-Meier survival curve analysis for overall survival among four patient groups grouped by the MTG-based prognostic signature and (g) KDR, (h) KIT, (i) VEGFA, (j) PD-1, (k) PD-L1, and (l) CTLA4. (The statistical method was a t-test with only one test and a log-rank test for a single factor, with only one test, and the reported P value was the P value).